These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 4150270)
1. Clinical and pharmacokinetic studies of minoxidil, a new antihypertensive agent. Chidsey CA Clin Sci Mol Med Suppl; 1973 Aug; 45 Suppl 1():171s-3. PubMed ID: 4150270 [No Abstract] [Full Text] [Related]
2. Combined therapy with vasodilator drugs and beta-adrenergic blockade in hypertension. A comparative study of minoxidil and hydralazine. Gottlieb TB; Katz FH; Chidsey CA Circulation; 1972 Mar; 45(3):571-82. PubMed ID: 4401051 [No Abstract] [Full Text] [Related]
3. Minoxidil in severe hypertension with renal failure. Effect of its addition to conventional antihypertensive drugs. Limas CJ; Freis ED Am J Cardiol; 1973 Mar; 31(3):355-61. PubMed ID: 4687850 [No Abstract] [Full Text] [Related]
5. [Beta blockaders in the treatment of hypertension. Part 2. Antihypertensive effect: hypotheses on the mechanism of action and practical methods of treatment]. Andrejak M; Fournier A; Hardin JM; Lambrey G; de Frémont JF; Coevoet B Coeur Med Interne; 1978; 17(3):381-400. PubMed ID: 31260 [No Abstract] [Full Text] [Related]
6. Antihypertensive agents--the race for third place. Smith SA; Littler WA J Clin Hosp Pharm; 1985 Jun; 10(2):113-22. PubMed ID: 2862165 [No Abstract] [Full Text] [Related]
12. Management of severe childhood hypertension with minoxidil: a controlled clinical study. Sinaiko AR; Mirkin BL J Pediatr; 1977 Jul; 91(1):138-42. PubMed ID: 874651 [TBL] [Abstract][Full Text] [Related]
13. The pharmacologic basis of antihypertensive therapy: The role of vasodilator drugs. Chidsey CA; Gottlieb TB Prog Cardiovasc Dis; 1974; 17(2):99-113. PubMed ID: 4153137 [No Abstract] [Full Text] [Related]
14. Pharmacologic approach to the management of childhood hypertension. Pruitt AW Pediatr Clin North Am; 1981 Feb; 28(1):135-44. PubMed ID: 7208133 [No Abstract] [Full Text] [Related]
15. Management of malignant hypertension. Grim CE Compr Ther; 1980 May; 6(5):43-8. PubMed ID: 7379487 [No Abstract] [Full Text] [Related]
16. Vasodilator drugs and resistant hypertension. Bannan LT; Beevers DG; Wright N Br Med J; 1980 Oct; 281(6247):1053-5. PubMed ID: 7427573 [No Abstract] [Full Text] [Related]
17. Minoxidil--haemodynamic and clinical experiences with a new peripheral vasodilator. Sannerstedt R; Brorson L; Berglund G; Werkö L Acta Med Scand; 1975 May; 197(5):409-14. PubMed ID: 238365 [TBL] [Abstract][Full Text] [Related]
18. [Treatment of severe arterial hypertension with a new peripheral vasodilator agent (minoxidil)]. Angelino PF; Lavezzaro G Minerva Cardioangiol; 1979 Jun; 27(6):359-64. PubMed ID: 381979 [No Abstract] [Full Text] [Related]
19. Treatment of refractory hypertension. Swales JD; Bing RF; Heagerty A; Pohl JE; Russell GI; Thurston H Lancet; 1982 Apr; 1(8277):894-6. PubMed ID: 6122111 [TBL] [Abstract][Full Text] [Related]
20. Minoxidil in refractory hypertension. Effects on blood pressure, plasma volume and muscle blood flow. Andersson O; Sivertsson R Acta Med Scand; 1979; 205(3):213-9. PubMed ID: 34316 [No Abstract] [Full Text] [Related] [Next] [New Search]